Literature DB >> 23475320

Gene analysis and dynamics of tumor stem cells in human glioblastoma cells after radiation.

Akiko Sasaki1, Takato Nakajo, Yuko Tsunoda, Gou Yamamoto, Yusuke Kobayashi, Mayumi Tsuji, Yuko Udaka, Tohru Mizutani, Katsuji Oguchi.   

Abstract

Glioblastoma is the most malignant central nervous system tumor. Patients with glioblastoma are treated with a combination of surgery, radiotherapy and chemotherapy; however, this effect is not satisfactory with regard to the prognosis. It is reported that the tumor stem cells affect recurrence, and radio- and chemotherapy resistance of the tumor, and that these cells play an important role in tumorigenesis and tumor progression. Using human glioblastoma cell lines (T98G and A172), irradiated (0, 30, 60 Gy) glioblastoma cells were prepared under the same conditions as clinical therapy. We analyzed cell proliferation rate, side population analysis by fluorescence-activated cell sorting and isolation of CD133⁺ cells, and performed genetic analysis (human stem cells) on these cells. We also investigated the difference in gene expression in the cells after radiation. The stem cell-related genes were highly expressed in the CD133⁺ cells compared with the CD133⁻ cells, suggesting that the cancer stem cells may be located in these CD133⁺ cells. In the T98G cell line, the cell proliferation rate of 30-Gy irradiated cells was higher than those of non-irradiated cells and 60-Gy irradiated cells. Stem cell-related genes were highly expressed in 30-Gy irradiated CD133⁺ T98G cells. In conclusion, we suggest that CD133⁺ cells may strongly affect tumor proliferation and the resistance against radiation therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475320     DOI: 10.1007/s13577-013-0060-0

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  21 in total

1.  A perivascular niche for brain tumor stem cells.

Authors:  Christopher Calabrese; Helen Poppleton; Mehmet Kocak; Twala L Hogg; Christine Fuller; Blair Hamner; Eun Young Oh; M Waleed Gaber; David Finklestein; Meredith Allen; Adrian Frank; Ildar T Bayazitov; Stanislav S Zakharenko; Amar Gajjar; Andrew Davidoff; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

2.  Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.

Authors:  Carlos Luzzani; Claudia Solari; Noelia Losino; Waisman Ariel; Leonardo Romorini; Carolina Bluguermann; Gustavo Sevlever; Lino Barañao; Santiago Miriuka; Alejandra Guberman
Journal:  Biochem Biophys Res Commun       Date:  2011-06-15       Impact factor: 3.575

Review 3.  Molecular models for vertebrate limb development.

Authors:  R L Johnson; C J Tabin
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

Review 4.  Stem cells and brain cancer.

Authors:  U Galderisi; M Cipollaro; A Giordano
Journal:  Cell Death Differ       Date:  2006-01       Impact factor: 15.828

5.  Dynamics of chronic myeloid leukaemia.

Authors:  Franziska Michor; Timothy P Hughes; Yoh Iwasa; Susan Branford; Neil P Shah; Charles L Sawyers; Martin A Nowak
Journal:  Nature       Date:  2005-06-30       Impact factor: 49.962

6.  Implications of thymidine labeling index in the growth kinetics of human solid tumors.

Authors:  T Sasaki; M Sakka
Journal:  Gan       Date:  1981-04

7.  Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression.

Authors:  Kai-Wen Hsu; Rong-Hong Hsieh; Kuo-Hung Huang; Anna Fen-Yau Li; Chin-Wen Chi; Tzu-Yin Wang; Min-Jen Tseng; Kou-Juey Wu; Tien-Shun Yeh
Journal:  Carcinogenesis       Date:  2012-05-10       Impact factor: 4.944

8.  Cancerous stem cells can arise from pediatric brain tumors.

Authors:  Houman D Hemmati; Ichiro Nakano; Jorge A Lazareff; Michael Masterman-Smith; Daniel H Geschwind; Marianne Bronner-Fraser; Harley I Kornblum
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205

9.  Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma.

Authors:  Adrian M Jubb; Lisa Browning; Leticia Campo; Helen Turley; Graham Steers; Gavin Thurston; Adrian L Harris; Olaf Ansorge
Journal:  Histopathology       Date:  2012-02-01       Impact factor: 5.087

10.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

View more
  3 in total

1.  Reduced PTEN expression and overexpression of miR-17-5p, -19a-3p, -19b-3p, -21-5p, -130b-3p, -221-3p and -222-3p by glioblastoma stem-like cells following irradiation.

Authors:  Takatoshi Tokudome; Akiko Sasaki; Mayumi Tsuji; Yuko Udaka; Hideto Oyamada; Hiromichi Tsuchiya; Katsuji Oguchi
Journal:  Oncol Lett       Date:  2015-08-11       Impact factor: 2.967

Review 2.  Potential applications of imaging and image-guided radiotherapy for brain metastases and glioblastoma to improve patient quality of life.

Authors:  Nam P Nguyen; Mai L Nguyen; Jacqueline Vock; Claire Lemanski; Christine Kerr; Vincent Vinh-Hung; Alexander Chi; Rihan Khan; William Woods; Gabor Altdorfer; Mark D'Andrea; Ulf Karlsson; Russ Hamilton; Fred Ampil
Journal:  Front Oncol       Date:  2013-11-19       Impact factor: 6.244

3.  Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.

Authors:  Gloria Perazzoli; Jose Prados; Raul Ortiz; Octavio Caba; Laura Cabeza; Maria Berdasco; Beatriz Gónzalez; Consolación Melguizo
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.